These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8176585)

  • 1. Immune-mediated regression of 'metastatic' neuroblastoma in the liver.
    Ishizu H; Bove KE; Ziegler MM; Arya G
    J Pediatr Surg; 1994 Feb; 29(2):155-9; discussion 159-60. PubMed ID: 8176585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-specific adhesion of neuroblastoma cells in vitro: correlation with their hepatic metastasis potential.
    Kuwashima N
    J Pediatr Surg; 1997 Apr; 32(4):546-51. PubMed ID: 9126751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of cytotoxic T lymphocytes induced by CD86-transfected tumor cells suppresses multi-organ metastases of C1300 neuroblastoma in mice.
    Enomoto A; Kato K; Yagita H; Okumura K
    Cancer Immunol Immunother; 1997 Jun; 44(4):204-10. PubMed ID: 9222278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
    Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of interleukin-2 immunotherapy with L-arginine.
    Lieberman MD; Nishioka K; Redmond HP; Daly JM
    Ann Surg; 1992 Feb; 215(2):157-65. PubMed ID: 1546902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior protective and therapeutic effects of IL-12 and IL-18 gene-transduced dendritic neuroblastoma fusion cells on liver metastasis of murine neuroblastoma.
    Iinuma H; Okinaga K; Fukushima R; Inaba T; Iwasaki K; Okinaga A; Takahashi I; Kaneko M
    J Immunol; 2006 Mar; 176(6):3461-9. PubMed ID: 16517714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental analysis of anti-tumor cytotoxic mechanism for hybrid resistance to mouse neuroblastoma].
    Yamasaki T; Moritake K; Kikuchi H; Kärre K; Ljunggren HG; Klein G
    No Shinkei Geka; 1990 Nov; 18(11):1015-22. PubMed ID: 2247194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose interferon gamma renders neuroblastoma more susceptible to interleukin-2 immunotherapy.
    Sigal RK; Lieberman MD; Reynolds JV; Shou J; Ziegler MM; Daly JM
    J Pediatr Surg; 1991 Apr; 26(4):389-95; discussion 395-6. PubMed ID: 1905348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells.
    Salcedo R; Stauffer JK; Lincoln E; Back TC; Hixon JA; Hahn C; Shafer-Weaver K; Malyguine A; Kastelein R; Wigginton JM
    J Immunol; 2004 Dec; 173(12):7170-82. PubMed ID: 15585838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
    Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
    Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow.
    Lode HN; Xiang R; Varki NM; Dolman CS; Gillies SD; Reisfeld RA
    J Natl Cancer Inst; 1997 Nov; 89(21):1586-94. PubMed ID: 9362156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative immunotherapy of murine C1300-neuroblastoma.
    Fowler CL; Brooks SP; Rossman JE; Cooney DR
    J Pediatr Surg; 1990 Feb; 25(2):229-37. PubMed ID: 1689384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to murine neuroblastoma: effects of in vitro culture of the tumor. Mitogen and mixed lymphocyte culture responses, interleukin-2 production, suppression and natural killer activity.
    Leclercq G; Willems J; Joniau M
    J Clin Lab Immunol; 1986 Nov; 21(3):117-23. PubMed ID: 2951523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
    Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
    J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen.
    Croce M; Meazza R; Orengo AM; Fabbi M; Borghi M; Ribatti D; Nico B; Carlini B; Pistoia V; Corrias MV; Ferrini S
    Cancer Immunol Immunother; 2008 Nov; 57(11):1625-34. PubMed ID: 18324400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice.
    Castriconi R; Dondero A; Cilli M; Ognio E; Pezzolo A; De Giovanni B; Gambini C; Pistoia V; Moretta L; Moretta A; Corrias MV
    Cancer Immunol Immunother; 2007 Nov; 56(11):1733-42. PubMed ID: 17426969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma.
    Lode HN; Dreier T; Xiang R; Varki NM; Kang AS; Reisfeld RA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2475-80. PubMed ID: 9482910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic analysis of the immunoregulation of murine neuroblastoma.
    Choi SH; Reynolds JV; Ziegler MM
    J Pediatr Surg; 1989 Jan; 24(1):15-9; Discussion 19-20. PubMed ID: 2524562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
    Saarloos MN; Khoo NK; Lala PK
    Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 in neuroblastoma: clinical perspectives based on biological studies.
    Rueda F; Martí F; Pardo N; Badell I; Peiró M; Bertran E; Villén E; García J; Cubells J
    Cancer Biother Radiopharm; 1996 Oct; 11(5):303-8. PubMed ID: 10851509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.